Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Obesity | Research

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study

Authors: Noushin Sadat Ahanchi, Seyed Saeed Tamehri Zadeh, Davood Khalili, Fereidoun Azizi, Farzad Hadaegh

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Aims

To identify sex specific trajectories of waist circumference (WC),triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and fasting plasma glucose (FPG) during adulthood and examine their associations with incident hypertension.

Methods

The cohort consisted of 5030 participants (2051 males) with at least 2 repeated measurement during a median of 12 years follow up. We identified trajectory groups using latent class growth mixture model, their association with hypertension was examined using multivariate Cox-regression analysis.

Results

We found 997 cases of hypertension (483 male). For both exposures, three distinct trajectory groups were identified in both genders. For WC, in women: low-increasing, 82.4%; high-stable, 13.4%; high-increasing, 4.2% and in men: stable, 94.6%; low-increasing, 3.6% and for high- increasing, 1.7%. For TG, in women: stable, 91.3%; decreasing, 5.9%; inverse U-shape, 2.8%; in men: stable, 89.7%; inverse U- shape, 6.2% and for decreasing, 4.1%.
Regarding WC, high stable and high-increasing trajectories were associated with hypertension in the multivariate model [(hazard ratio (HR) = 1.66 (95% CI 1.26–2.20) and 2.78(1.79–3.60), respectively]. Among men, this association was shown only for the low-increasing trajectory [2.76: 1.49–5.10]. For TG, among women decreasing and inverse U-shape trajectories were significantly associated with hypertension in the multivariate model [1.32:1.01–1.76] and [2.23:1.58–3.23, respectively].
We did not find any impact of increasing trajectories of FPG and HDL-C on incident hypertension. Considering TC, all individuals followed a stable trajectory.

Conclusion

WC dynamic changes in both gender and TG trajectory among women were significantly associated with incident hypertension.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fahed AC, El-Hage-Sleiman A-KM, Farhat TI, Nemer GM. Diet, genetics, and disease: a focus on the Middle East and North Africa region. Journal of Nutrition and Metabolism. 2012. Fahed AC, El-Hage-Sleiman A-KM, Farhat TI, Nemer GM. Diet, genetics, and disease: a focus on the Middle East and North Africa region. Journal of Nutrition and Metabolism. 2012.
2.
go back to reference Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.CrossRef Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.CrossRef
3.
go back to reference Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, et al. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health. 2017;17(1):915.CrossRef Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, et al. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health. 2017;17(1):915.CrossRef
4.
go back to reference Asgari S, Khalili D, Mehrabi Y, Kazempour-Ardebili S, Azizi F, Hadaegh F. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press. 2016;25(3):177–83.CrossRef Asgari S, Khalili D, Mehrabi Y, Kazempour-Ardebili S, Azizi F, Hadaegh F. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press. 2016;25(3):177–83.CrossRef
5.
go back to reference Echouffo-Tcheugui JB, Batty GD, Kivimäki M, Kengne AP. Risk models to predict hypertension: a systematic review. PLoS ONE. 2013;8(7):e67370.CrossRef Echouffo-Tcheugui JB, Batty GD, Kivimäki M, Kengne AP. Risk models to predict hypertension: a systematic review. PLoS ONE. 2013;8(7):e67370.CrossRef
6.
go back to reference Sun D, Liu J, Xiao L, Liu Y, Wang Z, Li C, et al. Recent development of risk-prediction models for incident hypertension: An updated systematic review. PLoS ONE. 2017;12(10):e0187240.CrossRef Sun D, Liu J, Xiao L, Liu Y, Wang Z, Li C, et al. Recent development of risk-prediction models for incident hypertension: An updated systematic review. PLoS ONE. 2017;12(10):e0187240.CrossRef
7.
go back to reference Ahanchi NS, Ramezankhani A, Munthali RJ, Asgari S, Azizi F, Hadaegh F. Body mass index trajectories from adolescent to young adult for incident high blood pressure and high plasma glucose. PLoS ONE. 2019;14(5):e0213828.CrossRef Ahanchi NS, Ramezankhani A, Munthali RJ, Asgari S, Azizi F, Hadaegh F. Body mass index trajectories from adolescent to young adult for incident high blood pressure and high plasma glucose. PLoS ONE. 2019;14(5):e0213828.CrossRef
8.
go back to reference Fan B, Yang Y, Dayimu A, Zhou G, Liu Y, Li S, et al. Body mass index trajectories during young adulthood and incident hypertension: a longitudinal cohort in Chinese population. J American Heart Association. 2019;8(8):e011937.CrossRef Fan B, Yang Y, Dayimu A, Zhou G, Liu Y, Li S, et al. Body mass index trajectories during young adulthood and incident hypertension: a longitudinal cohort in Chinese population. J American Heart Association. 2019;8(8):e011937.CrossRef
9.
go back to reference Moghimi N, Davatchi F, Rahimi E, Saidi A, Rashadmanesh N, Moghimi S, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj. Iran Clinical Rheumatol. 2015;34(3):535–43.CrossRef Moghimi N, Davatchi F, Rahimi E, Saidi A, Rashadmanesh N, Moghimi S, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj. Iran Clinical Rheumatol. 2015;34(3):535–43.CrossRef
10.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef
11.
go back to reference Muthén B. The potential of growth mixture modelling. Infant and Child Development. 2006;15(6):623.CrossRef Muthén B. The potential of growth mixture modelling. Infant and Child Development. 2006;15(6):623.CrossRef
12.
go back to reference Muthén L, Muthén B. Mplus statistical modeling software (Version 6.12). Los Angeles: Muthén & Muthén. 2011. Muthén L, Muthén B. Mplus statistical modeling software (Version 6.12). Los Angeles: Muthén & Muthén. 2011.
13.
go back to reference Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatr Psychol. 2014;39(2):188–203.CrossRef Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatr Psychol. 2014;39(2):188–203.CrossRef
14.
go back to reference Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling A multidisciplinary J. 2007;14(4):535–69.CrossRef Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling A multidisciplinary J. 2007;14(4):535–69.CrossRef
15.
go back to reference Wang M, Bodner TE. Growth mixture modeling: Identifying and predicting unobserved subpopulations with longitudinal data. Organizational Research Methods. 2007;10(4):635–56.CrossRef Wang M, Bodner TE. Growth mixture modeling: Identifying and predicting unobserved subpopulations with longitudinal data. Organizational Research Methods. 2007;10(4):635–56.CrossRef
16.
go back to reference Jung T, Wickrama KA. An introduction to latent class growth analysis and growth mixture modeling. Soc Pers Psychol Compass. 2008;2(1):302–17.CrossRef Jung T, Wickrama KA. An introduction to latent class growth analysis and growth mixture modeling. Soc Pers Psychol Compass. 2008;2(1):302–17.CrossRef
17.
go back to reference McLachlan GJ, Peel D. Finite mixture models: John Wiley & Sons; 2004. McLachlan GJ, Peel D. Finite mixture models: John Wiley & Sons; 2004.
18.
go back to reference AZIZI F, Khalili D, Aghajani H, ESTEGHAMATI A, Hosseinpanah F, DELAVARI A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. 2010. AZIZI F, Khalili D, Aghajani H, ESTEGHAMATI A, Hosseinpanah F, DELAVARI A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. 2010.
19.
go back to reference Koohpayehzadeh J, Etemad K, Abbasi M, Meysamie A, Sheikhbahaei S, Asgari F, et al. Gender-specific changes in physical activity pattern in Iran: national surveillance of risk factors of non-communicable diseases (2007–2011). International J Public Health. 2014;59(2):231–41.CrossRef Koohpayehzadeh J, Etemad K, Abbasi M, Meysamie A, Sheikhbahaei S, Asgari F, et al. Gender-specific changes in physical activity pattern in Iran: national surveillance of risk factors of non-communicable diseases (2007–2011). International J Public Health. 2014;59(2):231–41.CrossRef
20.
go back to reference Chuang S-Y, Chou P, Hsu P-F, Cheng H-M, Tsai S-T, Lin I-F, et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens. 2006;19(8):788–95.CrossRef Chuang S-Y, Chou P, Hsu P-F, Cheng H-M, Tsai S-T, Lin I-F, et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens. 2006;19(8):788–95.CrossRef
21.
go back to reference Miyatake N, Matsumoto S, Fujii M, Numata T. Reducing waist circumference by at least 3 cm is recommended for improving metabolic syndrome in obese Japanese men. Diabetes Res Clin Pract. 2008;79(2):191–5.CrossRef Miyatake N, Matsumoto S, Fujii M, Numata T. Reducing waist circumference by at least 3 cm is recommended for improving metabolic syndrome in obese Japanese men. Diabetes Res Clin Pract. 2008;79(2):191–5.CrossRef
22.
go back to reference Zhao Y, Zhang M, Luo X, Wang C, Li L, Zhang L, et al. Association of 6-year waist circumference gain and incident hypertension. Heart. 2017;103(17):1347–52.CrossRef Zhao Y, Zhang M, Luo X, Wang C, Li L, Zhang L, et al. Association of 6-year waist circumference gain and incident hypertension. Heart. 2017;103(17):1347–52.CrossRef
23.
go back to reference Bombelli M, Facchetti R, Sega R, Carugo S, Fodri D, Brambilla G, et al. Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension. 2011;58(6):1029–35.CrossRef Bombelli M, Facchetti R, Sega R, Carugo S, Fodri D, Brambilla G, et al. Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension. 2011;58(6):1029–35.CrossRef
24.
go back to reference Poirier P, Lemieux I, Mauriege P, Dewailly E, Blanchet C, Bergeron J, et al. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension. 2005;45(3):363–7.CrossRef Poirier P, Lemieux I, Mauriege P, Dewailly E, Blanchet C, Bergeron J, et al. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension. 2005;45(3):363–7.CrossRef
25.
go back to reference Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension. 1991;17(6_pt_2):969–76. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension. 1991;17(6_pt_2):969–76.
26.
go back to reference Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J American Heart Association. 2016;5(3):e003053.CrossRef Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J American Heart Association. 2016;5(3):e003053.CrossRef
27.
go back to reference Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, et al. Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study. Global Heart. 2020;15(1). Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, et al. Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study. Global Heart. 2020;15(1).
28.
go back to reference Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women. J Hum Hypertens. 2012;26(9):525.CrossRef Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women. J Hum Hypertens. 2012;26(9):525.CrossRef
29.
go back to reference Zhang L, Li J-l, Zhang L-l, Guo L-l, Li H, Li D. Association and interaction analysis of body mass index and triglycerides level with blood pressure in elderly individuals in China. BioMed research international. 2018;2018. Zhang L, Li J-l, Zhang L-l, Guo L-l, Li H, Li D. Association and interaction analysis of body mass index and triglycerides level with blood pressure in elderly individuals in China. BioMed research international. 2018;2018.
30.
go back to reference Sánchez-Íñigo L, Navarro-González D, Pastrana-Delgado J, Fernández-Montero A, Martínez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–65.CrossRef Sánchez-Íñigo L, Navarro-González D, Pastrana-Delgado J, Fernández-Montero A, Martínez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–65.CrossRef
31.
go back to reference Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997;95(1):5–7.CrossRef Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997;95(1):5–7.CrossRef
32.
go back to reference Urbina EM, Srinivasan S, Kieltyka R, Tang R, Bond M, Chen W, et al. Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study. Atherosclerosis. 2004;176(1):157–64.CrossRef Urbina EM, Srinivasan S, Kieltyka R, Tang R, Bond M, Chen W, et al. Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study. Atherosclerosis. 2004;176(1):157–64.CrossRef
33.
go back to reference Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed
34.
go back to reference Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130–8.CrossRef Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130–8.CrossRef
35.
go back to reference Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health. 2009;9(1):426.CrossRef Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health. 2009;9(1):426.CrossRef
36.
go back to reference Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13(1):20.CrossRef Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13(1):20.CrossRef
37.
go back to reference Arnett DK, McGovern PG, Jacobs DR Jr, Shahar E, Duval S, Blackburn H, et al. Fifteen-year trends in cardiovascular risk factors (1980–1982 through 1995–1997) the Minnesota Heart Survey. Am J Epidemiol. 2002;156(10):929–35.CrossRef Arnett DK, McGovern PG, Jacobs DR Jr, Shahar E, Duval S, Blackburn H, et al. Fifteen-year trends in cardiovascular risk factors (1980–1982 through 1995–1997) the Minnesota Heart Survey. Am J Epidemiol. 2002;156(10):929–35.CrossRef
38.
go back to reference Palmer MK, Toth PP. Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: An NHANES analysis (2003‐2004 to 2013‐2014). Obesity. 2019;27(2):309–14. Palmer MK, Toth PP. Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: An NHANES analysis (2003‐2004 to 2013‐2014). Obesity. 2019;27(2):309–14.
39.
go back to reference Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2010;39(2):504–18.CrossRef Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2010;39(2):504–18.CrossRef
40.
go back to reference Jayedi A, Rashidy‐Pour A, Khorshidi M, Shab‐Bidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose–response meta‐analysis of more than 2.3 million participants. Obesity reviews. 2018;19(5):654–67. Jayedi A, Rashidy‐Pour A, Khorshidi M, Shab‐Bidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose–response meta‐analysis of more than 2.3 million participants. Obesity reviews. 2018;19(5):654–67.
Metadata
Title
Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
Authors
Noushin Sadat Ahanchi
Seyed Saeed Tamehri Zadeh
Davood Khalili
Fereidoun Azizi
Farzad Hadaegh
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-02749-x

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.